Patent details

Basic Information

Publication number:

EP0663916

PCT Application Number:

PCT/EP/93/02604

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP939208229

PCT Publication Number:

WO/94/09010

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

O-ALKYLATED RAPAMYCIN DERIVATIVE AND ITS USE, PARTICULARLY AS IMMUNOSUPPRESSANT

French Title of Invention:

DERIVE O-ALKYLE DE LA RAPAMYCINE ET SON UTILISATION, EN PARTICULIER COMME IMMUNOSUPPRESSEUR

German Title of Invention:

O-ALKYLIERTE RAPAMYCIN-DERIVAT UND SEINE VERWENDUNG INSBESONDERE ALS IMMUNOSUPPRESSIVA

SPC Number:

91104

Dates

Filing date:

24/09/1993

Grant date:

25/11/1998

EP Publication Date:

25/11/1998

PCT Publication Date:

28/04/1994

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/07/1995

EP B1 Publication Date:

25/11/1998

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/09/2013

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/03/2019

 

 

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

History of Owners

From:

26/06/2001

To:

13/03/2019

Name:

NOVARTIS AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

COTTENS Sylvain

Address:

Switzerland (CH)

2

Name:

SEDRANI Richard

Address:

Switzerland (CH)

Licencee

Name:

N.V. Novartis Pharma S.A.

From:

27/03/2019

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

To:

Priority

Priority Number:

9221220

Priority Date:

09/10/1992

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 498/18;

Publication

Bulletin

1

Bulletin Heading:

MED

Bulletin edition number:

2019/06

Publication date:

06/05/2019

Description:

Section K : Modifications and recordals into the register

2

Bulletin Heading:

CO

Bulletin edition number:

2019/05

Publication date:

11/04/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000121A

Date Registered:

13/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20190000139B

Date Registered:

27/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Not Exclusive

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Luxembourg (LU)

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

N.V. Novartis Pharma S.A.

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:

Address:

Filing date	Document type	Number of pages
21/03/2019	Outgoing Correspondence	2
13/03/2019	Request For Change	6
27/03/2019	Request For Change	6
01/04/2019	Outgoing Correspondence	1